2021 research period for North America is officially open
March 24, 2021
Research team is now accepting firm submissions, due June 1
US
Corporate
| General Corporate — Highly Recommended |
|---|
| Cooley |
| Goodwin Procter |
| Hogan Lovells |
| Latham & Watkins |
| Ropes & Gray |
| WilmerHale |
| General Corporate — Recommended |
|---|
| Arnold & Porter |
| Covington & Burling |
| Dechert |
| Fenwick & West |
| Gibson Dunn & Crutcher |
| Jones Day |
| Morgan Lewis & Bockius |
| Sidley Austin |
| Wilson Sonsini Goodrich & Rosati |
General Patent Litigation
| General Patent Litigation — Recommended |
|---|
| Arnold & Porter |
| Cooley |
| Covington & Burling |
| Durie Tangri |
| Gibson Dunn & Crutcher |
| Knobbe Martens |
| Mayer Brown |
| McAndrews Held & Malloy |
| Morgan Lewis & Bockius |
| Sterne Kessler Goldstein & Fox |
| Venable |
| Weil Gotshal & Manges |
Hatch-Waxman Patent Litigation (Branded)
| Hatch-Waxman Patent Litigation (Branded) — Highly Recommended |
|---|
| Covington & Burling |
| Finnegan Henderson Farabow Garrett & Dunner |
| Fish & Richardson |
| Paul Hastings |
| Sidley Austin |
| Venable |
| Williams & Connolly |
| WilmerHale |
| Hatch-Waxman Patent Litigation (Branded) — Recommended |
|---|
| Arnold & Porter |
| Bartlit Beck |
| Dechert |
| Jones Day |
| Kirkland & Ellis |
| Latham & Watkins |
| Mayer Brown |
| O'Melveny & Myers |
| Quinn Emanuel Urquhart & Sullivan |
Licensing & Collaboration
| Licensing & Collaboration — Highly Recommended |
|---|
| Cooley |
| Covington & Burling |
| Goodwin Procter |
| Latham & Watkins |
| Ropes & Gray |
| WilmerHale |
| Wilson Sonsini Goodrich & Rosati |
| Licensing & Collaboration — Recommended |
|---|
| Baker McKenzie |
| Dechert |
| Fenwick & West |
| Hogan Lovells |
| Jones Day |
| King & Spalding |
| Morgan Lewis & Bockius |
| Sidley Austin |
Patent Prosecution
| Lawyer | Section | Practice Area | Location |
|---|---|---|---|
| Antler, Adriane M | Intellectual Property | Patent Prosecution, Patent Strategy & Management, General Patent Litigation | New York City |
| Briggs, Thomas A | Financial & Corporate | Venture Capital, Licensing & Collaboration, Mergers & Acquisitions | San Diego |
| Castanias, Gregory A | Intellectual Property | General Patent Litigation, Hatch-Waxman Patent Litigation | Washington, D.C. |
| Griffith, Calvin | Intellectual Property | General Patent Litigation | Cleveland |
| Hogan, Carol | Non-IP Litigation & Enforcement | Product Liability | Chicago |
| Insogna, Anthony M | Intellectual Property | Patent Prosecution, General Patent Litigation, Hatch-Waxman Patent Litigation | San Diego |
| Nachlis, Warren L | Financial & Corporate | Corporate, Venture Capital, Licensing & Collaboration, Mergers & Acquisitions | New York City |
| , {{displayValue}} {{displayValue}} {{displayValue}} | , {{displayValue}} {{displayValue}} {{displayValue}} | , {{displayValue}} {{displayValue}} {{displayValue}} | , {{displayValue}} {{displayValue}} {{displayValue}} |
Intellectual Property
Jones Day
Jones Day's IP group is highly ranked for general patent litigation with additional marks for Hatch-Waxman disputes and patent prosecution. The firm is notable for its broad geographic footprint, including major life sciences hubs New York and San Diego.
Global IP co-chair Anthony Insogna focuses his practice on a mix of patent litigation and portfolio management. His past representations include Celgene, AbbVie, and Merck entity Idenix, the last of which involved the largest damages award ever in a patent infringement case. Litigator Calvin Griffith has handled patent suits spanning numerous technology areas, including life sciences cases for Merck, Johnson & Johnson and AbbVie. Greg Castanias was shortlisted for the IP Appellate Litigator of the Year award in 2020 by LMG Life Sciences.
Patent prosecution co-head Adriane Antler is one of the firm's leading strategists for IP portfolios. She has expertise in matters related to biotechnology, pharmaceuticals and bioinformatics. Notable representations include Biogen, Sloan-Kettering Cancer Center and Acorda therapeutics. She was shortlisted for the New York Patent Strategy Attorney of the Year award by LMG Life Sciences.